Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3020 |
|
Actual shortage: | 235 (8%) | |
Anticipated shortage: | 19 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2757 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
28 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-SITAGLIPTIN MALATE | 25MG | TABLET | Resolved | 2023-02-09 | 2023-04-06 | 184112 |
APO-QUETIAPINE FUMARATE | 25MG | TABLET (IMMEDIATE RELEASE) | Resolved | 2023-03-09 | 2023-04-14 | 186586 |
APO-TETRABENAZINE | 25MG | TABLET | Resolved | 2023-06-02 | 2023-06-23 | 193603 |
APO-TETRABENAZINE | 25MG | TABLET | Resolved | 2023-08-23 | 2023-10-06 | 202818 |
APO-PREGABALIN | 25MG | CAPSULE | Resolved | 2023-09-01 | 2023-10-20 | 203560 |
APO-SERTRALINE | 25MG | CAPSULE | Resolved | 2023-09-15 | 2023-10-06 | 204420 |
APO-HYDRALAZINE | 25MG | TABLET TABLET | Resolved | 2023-09-22 | 2023-11-06 | 204999 |
APO-METOPROLOL | 25MG | TABLET | Resolved | 2023-10-20 | 2023-12-01 | 207728 |
APO-SERTRALINE | 25MG | CAPSULE | Resolved | 2023-11-10 | 2024-01-19 | 209945 |
APO-TETRABENAZINE | 25MG | TABLET | Resolved | 2024-01-05 | 2024-02-02 | 215212 |
APO-METOPROLOL | 25MG | TABLET | Resolved | 2024-01-05 | 2024-03-22 | 215233 |
APO-CARVEDILOL | 25MG | TABLET | Actual shortage | 2024-01-12 | 2024-01-12 | 215952 |
APO-AMPHETAMINE XR | 25MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2024-01-12 | 2024-03-01 | 215964 |
APO-HYDRALAZINE | 25MG | TABLET TABLET | Resolved | 2024-01-19 | 2024-04-05 | 216650 |
APO-QUETIAPINE FUMARATE | 25MG | TABLET (IMMEDIATE RELEASE) | Actual shortage | 2024-01-19 | 2024-02-23 | 216699 |
APO-PREGABALIN | 25MG | CAPSULE | Anticipated shortage | 2024-01-19 | 2024-01-19 | 216732 |
ANAFRANIL | 25MG | TABLET | Resolved | 2024-03-15 | 2024-03-22 | 222473 |
APO-SERTRALINE | 25MG | CAPSULE | Actual shortage | 2024-03-15 | 2024-04-26 | 222481 |
APO-SITAGLIPTIN MALATE | 25MG | TABLET | Actual shortage | 2024-04-12 | 2024-04-12 | 224977 |
APO-NAPRO-NA | 275MG | TABLET | Resolved | 2018-05-15 | 2018-10-05 | 49499 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71032 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71035 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71038 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71051 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71057 | ||
ACID CONTROL | Discontinued | 2019-01-04 | 2019-01-04 | 71198 | ||
APO-RIZATRIPTAN RPD | Discontinued | 2019-01-04 | 2019-04-04 | 71334 | ||
APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78141 | ||
APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78144 | ||
APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83971 | ||
APO-ALMOTRIPTAN | Discontinued | 2019-05-13 | 2019-05-13 | 83976 | ||
APO-AMOXI CLAV 250MG/62.5MG PER 5ML | Discontinued | 2019-05-13 | 2019-05-13 | 83981 | ||
APO-AMOXI CLAV | Discontinued | 2019-05-17 | 2019-05-18 | 84392 | ||
APO-CEFPROZIL | Discontinued | 2019-05-17 | 2019-05-18 | 84396 | ||
APO-CEFPROZIL | Discontinued | 2019-06-12 | 2019-06-12 | 86542 | ||
APO-CIPROFLOX | Discontinued | 2019-06-12 | 2019-06-12 | 86547 | ||
APO-EXEMESTANE | Discontinued | 2019-06-12 | 2019-06-12 | 86552 | ||
APO-GEMFIBROZIL CAP 300MG USP | Discontinued | 2019-06-12 | 2019-06-12 | 86557 |